Jun 06, 2017
In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
2. 08:24 AM
Ingredients for water could be made on surface of moon, a chemical factory
3. 08:17 AM
Marine ecosystems changing color influenced by climate change
4. 08:15 AM
Innovative nanocoating technology harnesses sunlight to degrade microplastics